Interferon-beta treatment in patients with childhood-onset multiple sclerosis.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 11562627.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We present a report of the use of interferon-beta before 18 years of age in 16 patients with childhood-onset multiple sclerosis. This study demonstrated that the treatment is safe and well tolerated.
Medical subject headings
- Adjuvants, Immunologic
- Interferon-beta
- Multiple Sclerosis